Steve ‘Snoopman’ Edwards proves that US health officials and the drug’s manufacturer, Gilead Pharmaceuticals, knew that remdesivir caused multiple organ failure, including kidney failure, before it was awarded emergency use authorization by the U.S. Food and Drug Administration in early May 2020.

Pharmageddon — Part 1: How masked bandits in the US FDA, NIH & CDC used Gilead’s Remdesivir to democide ‘Covid-19 patients’ across America — in cahoots with the UN’s World Health Organization, two US universities and two medical journals

This heretical investigation shows the anatomy of medical democide inflicted upon an unwitting American people under the rubric of the so-called global pandemic. The mass execution of patients with the courses of alleged anti-viral drug remdesivir occurred under the direction of health officials.

At the beginning of May 2020, when the Food and Drug Administration issued an Emergency Use Authorization (EUA) to permit administering of an experimental drug for the treatment of hospitalized Covid-19 adults and children — many hospitals across the United States of America became mechanisms of state-sanctioned mass murder, or democide.

Democide is defined by R.J Rummel in his 1994 book, Death by Government, as state-sanctioned murder of any domestic person, or civilian people by government officials, who act with the approval of the highest officials or state policy, whether explicitly or implicitly, and includes genocide, politicide and mass murder.

The drug, remdesivir — which is marketed as Veklury — was previously made available on ‘compassionate use’ grounds for over 1800 coronavirus patients from January 25 2020 in the United States, according to an April 10 2020 press release by pharmaceutical manufacturer, Gilead Sciences Inc.i

Shockingly, Gilead’s ‘compassionate use’ rhetoric was packaged with sinister weaponized ironic humor, because the company knew the drug’s lethality, as this study will show. Indeed, remdesivir stood out as the only drug that killed over half of the humans in its cohort, during a four-drug trial during 2019, ostensibly conducted to combat an Ebola virus outbreak in the African Republic of Congo.

One U.S. doctor’s curiosity was aroused when he noticed from mid-May 2020, numerous doctors in New York all remarking in the public media that they had never seen a respiratory virus cause kidney failure.iii

The medical doctor, Bryan Ardis, wondered what drugs the doctors were prescribing to hospitalized Covid-19 patients, and he found it was remdesivir.

He had never heard of the drug.

Dr Ardis — who founded what became the North Texas Healing Centerii — looked up the US National Institutes of Health website to learn about remdesivir. The NIH website cited the trial in the Congo to treat Ebola virus, and Dr Ardis saw the medication was distinguished for having the highest mortality rate among the four drugs trialed without a proper control group given placebo treatment.


Comments powered by CComment